Skip to main content

Table 1 Patients’ characteristics at baseline and 6 months after treatment with intragastric balloon (IGB)

From: Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome

 

Baseline (n = 50)

6 months (n = 39)

p value

BDI

16 (1–32)

6 (0–45)

0.0019

HADS-depression

7 (1–14)

4 (0–18)

0.0345

HADS-anxiety

8 (1–18)

5 (0–20)

0.0066

  1. These results refer only to patients who completed the study
  2. Data Median (minimum–maximum)
  3. BDI Beck Depression Inventory; HADS hospital anxiety and depression scale